Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis

Cornea

Volumn 29, Issue 8, 2010, Pages 871-877

  Haque, Reza M ^a   Torkildsen, Gail L ^b,c   Brubaker, Kurt ^a   Zink, Richard C ^a   Kowalski, Regis P ^d   Mah, Francis S ^d   Pflugfelder, Stephen C ^e  

^a Inspire Pharmaceuticals   (United States)

^b Ora Inc   (United States)

^c Andover Eye Associates   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e CULLEN EYE INSTITUTE   (United States)

Author keywords

azithromycin; blepharitis; inflammation

Indexed keywords

AZITHROMYCIN; CYTOKINE; ANTIINFECTIVE AGENT; EYE DROPS;

ADULT; ARTICLE; BACTERIUM CULTURE; BLEPHARITIS; BLURRED VISION; CLINICAL ARTICLE; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM XEROSIS; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DYSGEUSIA; EYE DISCHARGE; EYE IRRITATION; EYE PAIN; EYELID DISEASE; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; MALE; MULTICENTER STUDY; NONHUMAN; OCULAR PRURITUS; OPEN STUDY; PRIORITY JOURNAL; SLIT LAMP; SYMPTOM; TEAR FILM; TREATMENT OUTCOME; VISUAL ACUITY; EYELID; FOLLOW UP; LACRIMAL FLUID; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PILOT STUDY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BLEPHARITIS; CYTOKINES; EYELIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PILOT PROJECTS; TEARS; TREATMENT OUTCOME;

EID: 77955172733     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181ca38a0     Document Type: Article

References (27)

1. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.
2. ® guidelines. Blepharitis. San Francisco, CA: AAO; November 2008. Available at: http://www.aao.org/ppp.
3. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye. 1991;5:395-411.
4. McCulley JP, Shine WE. Changing concepts in the diagnosis and management of blepharitis. Cornea. 2000;19:650-658.
5. Cher I. Chronic blepharitis: eyelid bugbear, not always bearing bugs. Mod MedAustr. May 1997:52-62.
6. Thygeson P. Etiology and treatment of blepharitis. Arch Ophthalmol. 1946;36:445-477.
7. Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984;68:524-528.
8. Smith RE, Flowers CW. Chronic blepharitis: a review. CLAO J. 1995;21: 200-207.
9. Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol. 2008;43:170-179.
10. Seal DV, McGill JI, Jacobs P, et al. Microbial and immunological investigations of chronic non-ulcerative blepharitis and meibomianitis. Br J Ophthalmol. 1985;69:604-611.
11. Mathers WD, Lane JA, Sutphin J, et al. Model for ocular tear film function. Cornea. 1996;15:110-119.
12. Seal D, Ficker L, Ramakrishnan M, et al. Role of staphylococcal toxin production in blepharitis. Ophthalmology. 1990;97:1684-1688.
13. Lam H, Bleiden L, De Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147:198-205.e1.
14. McClellan KA. Mucosal defense of the outer eye. Surv Ophthalmol. 1997; 42:233-246.
15. Thygeson P. Etiology and treatment of blepharitis. A study in military personnel. Arch Ophthalmol. 1946;36:445-457.
16. Groden LR, Murphy B, Rodnite J, et al. Lid flora in blepharitis. Cornea. 1991;10:50-53.
17. Bassler BL, Losick R. Bacterially speaking. Cell. 2006;125:237-246.
18. Graham JE, Moore JE, Jiru X, et al. Ocular pathogen or commensal: a PCR-based study ofsurface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci. 2007;48:5616-5623.
19. Abelson MB, Heller W, Shapiro AM, et al. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial. Am J Ophthalmol. 2008;145:959-965.
20. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immuno- modulatory effects of macrolides. Am J Med. 2004;117(Suppl 9A): S5-S11.
21. Culic O, Erakovic V Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol. 2001;429:209-229.
22. Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther. 2008;25:858-870.
23. Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol. 2008;43:170-179.
24. Nakamura Y, Sotozono C, Kinoshita S. Inflammatory cytokines in human tears. Curr Eye Res. 1998;17:636-636
25. Pflugfelder SG, Beuerman RW, Stern ME. Dry Eye and Ocular Surface Disorders. 1st ed. New York, NY: Marcel Dekker, Inc, 2004:124-125.
26. Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Review Microbiol. 2001;55:165-199.
27. Willcox MD, Zhu H, Conibear TC, et al. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis. Microbiology. 2008;154(pt 8):2184-2194.